Seizure prophylaxis in glioma surgery: a synopsis from the SPRING RCT

Michael D Jenkinson; Helen Bulbeck; Jade Carruthers; James A. Burns; Sarah Lessels; Richard Dobbie; R. Watson; Ciara Gribben; Alasdair G Rooney; Gerard Thompson; Tomos James Robinson; Luke Vale; Sara Erridge; Colin Watts; Anthony G Marson; R. Grant

doi:10.3310/gjmj1815

August 15, 2025Health Technology AssessmentOpen Access

Seizure prophylaxis in glioma surgery: a synopsis from the SPRING RCT

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the impact of seizure prophylaxis in glioma surgeries using data from the SPRING RCT.
Conducted a randomized controlled trial (RCT)
Focused on glioma surgery patients
Assessed the effectiveness of seizure prophylaxis
Demonstrated potential benefits of seizure prophylaxis in reducing postoperative seizures
Highlighted the need for further evaluation in clinical practice

Implication

Research shows seizure prophylaxis can improve outcomes in glioma surgeries, suggesting effectiveness in surgical settings.

Abstract

This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 16/31/136.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jenkinson et al. (2025) studied this question.

synapsesocial.com/papers/69b2585696eeacc4fcec7e04 https://doi.org/10.3310/gjmj1815

View Full Paper

Ask AI

Bookmark

Share

Seizure prophylaxis in glioma surgery: a synopsis from the SPRING RCT

Key Points

Implication

Abstract

Discussion

Cite This Study

Seizure prophylaxis in glioma surgery: a synopsis from the SPRING RCT

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from Health Technology Assessment

Keep reading

More related papers

More from Health Technology Assessment